Lipid-lowering therapy in patients with renal disease
- 1 July 1995
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 48 (1) , 188-198
- https://doi.org/10.1038/ki.1995.284
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- THE EFFECTS OF PRAVASTATIN ON HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1992
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Effects of protein intake variation and omega-3 polyunsaturated fatty acids on renal function in chronic renal diseaseLife Sciences, 1987
- Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patientsKidney International, 1987
- Exercise Training Reduces Coronary Risk and Effectively Rehabilitates Hemodialysis PatientsNephron, 1986
- Response Patterns to DL-Carnitine in Patients on Maintenance HaemodialysisNephron, 1982
- Metabolic effects of exercise training in hemodialysis patientsKidney International, 1980
- CARNITINE IMPROVES LIPID ANOMALIES IN HAEMODIALYSIS PATIENTSThe Lancet, 1980
- Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on HemodialysisNew England Journal of Medicine, 1979